These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

339 related items for PubMed ID: 8032628

  • 1. The effects of chronic imidazoline drug treatment on glial fibrillary acidic protein concentrations in rat brain.
    Olmos G, Alemany R, Escriba PV, García-Sevilla JA.
    Br J Pharmacol; 1994 Apr; 111(4):997-1002. PubMed ID: 8032628
    [Abstract] [Full Text] [Related]

  • 2. LSL 60101, a selective ligand for imidazoline I2 receptors, on glial fibrillary acidic protein concentration.
    Alemany R, Olmos G, Escribá PV, Menargues A, Obach R, García-Sevilla JA.
    Eur J Pharmacol; 1995 Jul 04; 280(2):205-10. PubMed ID: 7589187
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
    Escribá PV, Alemany R, Sastre M, Olmos G, Ozaita A, García-Sevilla JA.
    Br J Pharmacol; 1996 Aug 04; 118(8):2029-36. PubMed ID: 8864539
    [Abstract] [Full Text] [Related]

  • 4. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1995 Feb 04; 114(4):837-45. PubMed ID: 7773544
    [Abstract] [Full Text] [Related]

  • 5. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
    Miralles A, Olmos G, Sastre M, Barturen F, Martin I, Garcia-Sevilla JA.
    J Pharmacol Exp Ther; 1993 Mar 04; 264(3):1187-97. PubMed ID: 8095548
    [Abstract] [Full Text] [Related]

  • 6. Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes.
    Alemany R, Olmos G, García-Sevilla JA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul 04; 356(1):39-47. PubMed ID: 9228188
    [Abstract] [Full Text] [Related]

  • 7. Characterization of brain imidazoline receptors in normotensive and hypertensive rats: differential regulation by chronic imidazoline drug treatment.
    Olmos G, Miralles A, Barturen F, Garcia-Sevilla JA.
    J Pharmacol Exp Ther; 1992 Mar 04; 260(3):1000-7. PubMed ID: 1545372
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [3H]-idazoxan binding to rabbit cerebral cortex recognises multiple imidazoline I2-type receptors: pharmacological characterization and relationship to monoamine oxidase.
    Renouard A, Widdowson PS, Cordi A.
    Br J Pharmacol; 1993 Jul 04; 109(3):625-31. PubMed ID: 8102932
    [Abstract] [Full Text] [Related]

  • 11. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G, Gabilondo AM, Miralles A, Escriba PV, García-Sevilla JA.
    Br J Pharmacol; 1993 Mar 04; 108(3):597-603. PubMed ID: 8385528
    [Abstract] [Full Text] [Related]

  • 12. Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
    Boronat MA, Olmos G, García-Sevilla JA.
    Br J Pharmacol; 1998 Sep 04; 125(1):175-85. PubMed ID: 9776358
    [Abstract] [Full Text] [Related]

  • 13. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
    Miralles A, Ribas C, Olmos G, García-Sevilla JA.
    J Neurochem; 1993 Nov 04; 61(5):1602-10. PubMed ID: 8228980
    [Abstract] [Full Text] [Related]

  • 14. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
    Hussain JF, Kendall DA, Wilson VG.
    Br J Pharmacol; 1993 Jul 04; 109(3):831-7. PubMed ID: 8102937
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.